| Vaccine (24) |  |
| Vaccine (24) | |
Vaccine report: More children than ever are being immunized, but 24 million infants in the world's poorest nations still do not receive routine immunization, according to a report by the World health organization, UNICEF and the World bank.
The 21 october State of the World's Vaccines and Immunization report says that although four in five children now have access to lifesaving vaccines,
at least another US$1 billion is needed annually to help raise immunization rates above 90%.%This would cover the rising costs of immunization
HIV vaccine doubt: Results of the largest-ever HIV-vaccine trial looked less impressive when full details were published formally last week (S. Rerks-Ngarm et al.
N. Engl. J. Med. doi: 10.1056/nejmoa0908492; 2009) than when they were outlined in a press release a month earlier.
In September, the trial was said to show that a vaccine combination reduced the risk of HIV infection by nearly one-third.
which specializes in vaccines and antibody therapies. Crucell's board of directors unanimously supports the deal, and shareholders will vote on the matter on 8 february.
#New vaccine against lung diseases in goats and sheepan intranasal spray was developed using local isolated bacterium in Malaysia
and it was found to provide better protection against infections by Mannheimia haemolytica bacterium than imported vaccines.
Universiti Putra Malaysia has launched a new vaccine against lung or pneumonic diseases in goats and sheep that was developed
The soft launch of STVAC7 the first intranasal spray vaccine for goats and sheep was officiated by the Deputy Minister of Science Technology and Innovation Datuk Dr Abu Bakar Mohamad Diah in a brief ceremony on 24.oct 2013.
The vaccine was developed and tested from 1998 to 2005 by UPM scientists led by Prof Dr Mohd Zamri Saad of the Faculty of Veterinary Medicine.
The patent for the STVAC7 vaccine Has been fed commercialised to Tech Sdn Bhd for RM4 million
and marketing of the vaccine said the Vice chancellor of UPM Prof Datuk Dr Mohd Fauzi Hj Ramlan when speaking at the ceremony.
He said he is confident that the vaccine could penetrate the local and foreign market
The company's collaboration with UPM would ensure that it would produce the STVAC7 vaccines under Good Manufacturing Practices (GMP)
and FTU were currently developing the standard operating procedure (SOP) for the mass production of the STVAC 7 vaccine using the GMP facilities of the service centre as well as product registration before marketing.
Meanwhile replying to questions Prof Dr Zamri said the STVAC7 is a vaccine against mannheimiosis
which unlike the imported vaccines has been demonstrated to provide protection against bacterium infection in the small ruminants like goats and sheep.
The current available vaccines against this disease are imported vaccines prepared using foreign strains. They are given via intramuscular injections.
The vaccines were found to be ineffective and expensive. Therefore STVAC7 was developed using local isolated bacterium that was found to be able to provide protection against infections by Mannheimia haemolytica bacterium A2 A7 and A9.
and technology could be modified to produce vaccines against other diseases of animals and humans. In fact the technology can be modified further to produce test kits for various diseases he said.
and cancer, develop vaccines and cell therapies, enable regenerative medicine, or make cancer cells self-destruct.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011